These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31876105)

  • 1. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
    Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
    Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms.
    El Hussein S; Wang W
    Cancers (Basel); 2024 Jun; 16(11):. PubMed ID: 38893237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
    Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
    Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X; Wu Y; Li C; Shen K; Li R
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?
    Osaki Y; Yokohama A; Saito A; Tahara K; Yanagisawa K; Ogawa Y; Ishizaki T; Mitsui T; Koiso H; Takizawa M; Uchiumi H; Saitoh T; Handa H; Murakami H; Tsukamoto N; Nojima Y
    PLoS One; 2013; 8(11):e81722. PubMed ID: 24312342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
    Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
    Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
    Roussel X; Garnache Ottou F; Renosi F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cell neoplasms.
    Lee YJ; Kim Y; Park SH; Jo JC
    Blood Res; 2023 Apr; 58(S1):90-95. PubMed ID: 37105563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
    Peng J; He S; Yang X; Huang L; Wei J
    Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
    Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
    Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm.
    Fei F; Liedtke M; Silva O
    Front Oncol; 2022; 12():903113. PubMed ID: 35875095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.
    El Hussein S; Wang W
    Br J Haematol; 2023 Mar; 200(5):545-555. PubMed ID: 36606610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian carcinoma cells influence differentiation of Lin-CD45RA- dendritic cell precursors into two mature subtypes in vitro.
    Chen LL; Ye F; Yu Y; Chen HZ; Zhang WW; Lü WG; Xie X
    Gynecol Oncol; 2009 Jan; 112(1):199-204. PubMed ID: 19022493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm.
    Wang W; Khoury JD; Miranda RN; Jorgensen JL; Xu J; Loghavi S; Li S; Pemmaraju N; Nguyen T; Medeiros LJ; Wang SA
    Haematologica; 2021 Apr; 106(4):1047-1055. PubMed ID: 32241840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
    Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells.
    Gong X; Li C; Wang Y; Rao Q; Mi Y; Wang M; Wei H; Wang J
    Blood Sci; 2022 Jan; 4(1):38-43. PubMed ID: 35399539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
    Beird HC; Khan M; Wang F; Alfayez M; Cai T; Zhao L; Khoury J; Futreal PA; Konopleva M; Pemmaraju N
    Blood Cancer J; 2019 Dec; 9(12):99. PubMed ID: 31811114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.